Levetiracetam is not effective for essential tremor

Clinical Neuropharmacology

Volumn 30, Issue 6, 2007, Pages 350-356

  Elble, Rodger J ^a   Lyons, Kelly E ^b   Pahwa, Rajesh ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Controlled clinical trial; Essential tremor; Levetiracetam

Indexed keywords

ATENOLOL; CLONAZEPAM; ETIRACETAM; GABAPENTIN; MIRTAZAPINE; PLACEBO; PRIMIDONE; PROPRANOLOL;

ABDOMINAL CRAMP; ADULT; AGED; ANXIETY; ARTHRALGIA; ARTICLE; AUTOMATION; BACKACHE; BALANCE IMPAIRMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESSENTIAL TREMOR; FAHN TOLOSA MARIN TREMOR RATING SCALE; FATIGUE; FEMALE; HEADACHE; HUMAN; LEG CRAMP; MALE; MUSCLE CRAMP; NAUSEA; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; SIDE EFFECT; TREMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CROSS-OVER STUDIES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; DRUG EVALUATION; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM;

EID: 37349012149     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013E31807A32C6     Document Type: Article

References (12)

1. Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005;64(12):2008-2020.
2. Elble RJ. Report from a U.S. conference on essential tremor. Mov Disord 2006;21(12):2052-2061.
3. Cereghino JJ, Biton V, Abou-Khalil B, et al. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000;55(2):236-242.
4. Sasa M. A new frontier in epilepsy: novel antiepileptogenic drugs. J Pharmacol Sci 2006;100:487-494.
5. Ondo WG, Jimenez JE, Vuong KD, et al. An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol 2004;27(6):274-277.
6. Sullivan KL, Hauser RA, Zesiewicz TA. Levetiracetam for the treatment of essential tremor. Mov Disord May 2005;20(5):640.
7. Handforth A, Martin FC. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor. Mov Disord 2004;19(10):1215-1221.
8. Bushara KO, Malik T, Exconde RE. The effect of levetiracetam on essential tremor. Neurology 2005;64(6):1078-1080.
9. Fahn S, Tolosa E, Marín C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders 2nd ed. Baltimore: Williams & Wilkins; 1993:225-234.
10. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13(suppl 3):2-23.
11. Elble RJ, Brilliant M, Leffler K, et al. Quantification of essential tremor in writing and drawing. Mov Disord 1996;11:70-78.
12. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research 4th ed. London: Blackwell Science Ltd; 2002:628-634.